Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Temodal recommended for approval in E.U.

Oct. 27, 1998

STAR study will compare raloxifene to tamoxifen for reducing risk of breast cancer

Oct. 26, 1998

Thalidomide designated orphan drug for multiple myeloma

Oct. 26, 1998

Camptosar receives final FDA approval for colorectal cancer

Oct. 26, 1998

Naamidine A identified as EGF receptor antagonist and antiproliferative agent

Oct. 26, 1998

Nonsteroid progesterone antagonists for cancer, gynecological disorders

Oct. 26, 1998

Beta-glucuronidase inhibitors as antitumor/antiinflammatory agents

Oct. 26, 1998

Potent antitumor activity, low toxicity observed in in vitro studies of aplidine

Oct. 23, 1998

Cell Therapeutics initiates phase I lisofylline trial for treatment of mucositis

Oct. 22, 1998

ODAC votes against Warner-Lambert's prostate cancer drug

Oct. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...